Myomo (MYO) EBIT per Share : $-0.27 (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Myomo EBIT per Share?

Myomo's EBIT per Share for the three months ended in Mar. 2024 was $-0.11. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.27.

During the past 3 years, the average EBIT per Share Growth Rate was 55.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was 58.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Myomo's EBIT per Share or its related term are showing as below:

MYO' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -8.4 Med: 57.3 Max: 59.1
Current: 55.4

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Myomo was 59.10% per year. The lowest was -8.40% per year. And the median was 57.30% per year.

MYO's 3-Year EBIT Growth Rate is ranked better than
92.17% of 728 companies
in the Medical Devices & Instruments industry
Industry Median: 5.65 vs MYO: 55.40

Myomo's EBIT for the three months ended in Mar. 2024 was $-3.89 Mil.

Myomo EBIT per Share Historical Data

The historical data trend for Myomo's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myomo EBIT per Share Chart

Myomo Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-19.49

-3.33

-1.76

-1.51

-0.28

Myomo Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-0.11	-0.04	-0.06	-0.07	-0.11

Myomo EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Myomo's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-8.232	/	29.499
=	-0.28

Myomo's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.889	/	36.753
=	-0.11

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.27

Myomo (AMEX:MYO) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Myomo EBIT per Share Related Terms

Thank you for viewing the detailed overview of Myomo's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Myomo (MYO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Myomo Inc (AMEX:MYO) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

0M61:Germany 0M61:Germany

Address

137 Portland Street, 4th Floor, Boston, MA, USA, 02114

Website

https://www.myomo.com

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the device to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Executives

Thomas F Kirk	director
Milton Mayo Morris	director	2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Paul R Gudonis	director, officer: Chief Executive Officer	9 HICKORY ROAD, MANCHESTER MA 01944
David A Henry	officer: Chief Financial Officer
Harry Kovelman	officer: Chief Medical Officer	C/O MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114
Yitzchak Jacobovitz	director	MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON MA 02114
Micah Mitchell	officer: Chief Commercial Officer	C/O MYOMO, INC., ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA 02139
Crowley Thomas Aloysius Jr.	director	19 ST CLAIR AV, SPRING LAKE NJ 07762
Cliff Conneighton	officer: Chief Marketing Officer	53 DEPOT ROAD, HOLLS NH 03049
Jonathan Naft	officer: VP, General Manager	C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Brandon M Green	officer: Chief Medical Officer	C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Ralph A Goldwasser	officer: Chief Financial Officer	BNN CORP, 150 CAMBRIDGEPARK DRIVE, CAMBRIDGE MA 02140
Davie Mendelsohn	officer: VP, Sales	C/O MYOMO, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Steve Sanghi	director	2355 W CHANDLER BLVD, CHANDLER AZ 85224-6199
Amy K. Knapp	director	75 N. MOUNTAIN AVE, MONTCLAIR NJ 07042